INTERLEUKIN-10 INDUCES B-LYMPHOCYTES FROM IGA-DEFICIENT PATIENTS TO SECRETE IGA

被引:120
作者
BRIERE, F
BRIDON, JM
CHEVET, D
SOUILLET, G
BIENVENU, F
GURET, C
MARTINEZVALDEZ, H
BANCHEREAU, J
机构
[1] HOP BOCAGE, UNITE NEPHROL & REANIMAT METAB, F-21034 DIJON, FRANCE
[2] HOP DEBROUSSE, F-69005 LYON, FRANCE
关键词
IGA DEFICIENCY; INTERLEUKIN-10; B LYMPHOCYTES; CD40; TRIGGERING; DIFFERENTIATION;
D O I
10.1172/JCI117354
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We have previously shown that human B lymphocytes cultured in the CD40 system, composed of an anti-CD40 mAb presented by a CD32-transfected fibroblastic cell line, proliferate hut do not secrete antibodies. However, the addition of particles of Staphylococcus aureus Cowan (SAC) induces B cell differentiation even in the absence of exogeneous cytokines (CD40/SAC system). Additionally, B lymphocytes cultured in the CD40 system in the presence of human IL-10, produce IgM, IgG, and IgA, and Tg levels are further increased by SAC. Here, we have studied the capacity of peripheral blood lymphocytes from patients with IgA deficiency (IgA-D) to secrete Igs, particularly IgA after CD40 triggering. Peripheral blood mononuclear cells (PBMNC) from IgA-D patients cultured in the CD40/SAC system produced IgM and IgG, but not IgA. The addition of IL-10 to the cultures, enhanced the production of IgM and IgG and most strikingly induced the production of high amounts of IgA. The addition of IL-10 to PBMNC from IgA-D patients activated through CD40 alone resulted in the production of IgA. Thus, SAC and anti-CD40 mAb stimulate B cells to differentiate into cells secreting IgG and IgM whereas IL-10 plays a central role in inducing B cells from IgA-D patients to differentiate into IgA secreting cells.
引用
收藏
页码:97 / 104
页数:8
相关论文
共 38 条
[1]   CD40 LIGAND GENE DEFECTS RESPONSIBLE FOR X-LINKED HYPER-IGM SYNDROME [J].
ALLEN, RC ;
ARMITAGE, RJ ;
CONLEY, ME ;
ROSENBLATT, H ;
JENKINS, NA ;
COPELAND, NG ;
BEDELL, MA ;
EDELHOFF, S ;
DISTECHE, CM ;
SIMONEAUX, DK ;
FANSLOW, WC ;
BELMONT, J ;
SPRIGGS, MK .
SCIENCE, 1993, 259 (5097) :990-993
[2]   IDENTIFICATION OF A SOURCE OF BIOLOGICALLY-ACTIVE CD40 LIGAND [J].
ARMITAGE, RJ ;
SATO, TA ;
MACDUFF, BM ;
CLIFFORD, KN ;
ALPERT, AR ;
SMITH, CA ;
FANSLOW, WC .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1992, 22 (08) :2071-2076
[3]   THE CD40 LIGAND, GP39, IS DEFECTIVE IN ACTIVATED T-CELLS FROM PATIENTS WITH X-LINKED HYPER-IGM SYNDROME [J].
ARUFFO, A ;
FARRINGTON, M ;
HOLLENBAUGH, D ;
LI, X ;
MILATOVICH, A ;
NONOYAMA, S ;
BAJORATH, J ;
GROSMAIRE, LS ;
STENKAMP, R ;
NEUBAUER, M ;
ROBERTS, RL ;
NOELLE, RJ ;
LEDBETTER, JA ;
FRANCKE, U ;
OCHS, HD .
CELL, 1993, 72 (02) :291-300
[4]   FREQUENCY OF SELECTIVE IGG SUBCLASS DEFICIENCY - A REAPPRAISAL [J].
AUCOUTURIER, P ;
MARIAULT, M ;
LACOMBE, C ;
PREUDHOMME, JL .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1992, 63 (03) :289-291
[5]   LONG-TERM HUMAN B-CELL LINES DEPENDENT ON INTERLEUKIN-4 AND ANTIBODY TO CD40 [J].
BANCHEREAU, J ;
DEPAOLI, P ;
VALLE, A ;
GARCIA, E ;
ROUSSET, F .
SCIENCE, 1991, 251 (4989) :70-72
[6]   AUTOANTIBODIES TO CYTOKINES - FRIENDS OR FOES [J].
BENDTZEN, K ;
SVENSON, M ;
JONSSON, V ;
HIPPE, E .
IMMUNOLOGY TODAY, 1990, 11 (05) :167-169
[7]   HUMAN INTERLEUKIN-10 INDUCES NAIVE SURFACE-IMMUNOGLOBULIN D+ (SIGD(+)) B-CELLS TO SECRETE IGG1 AND IGG3 [J].
BRIERE, F ;
SERVETDELPRAT, C ;
BRIDON, J ;
SAINTREMY, JM ;
BANCHEREAU, J .
JOURNAL OF EXPERIMENTAL MEDICINE, 1994, 179 (02) :757-762
[8]   EPSTEIN-BARR-VIRUS TRANSFORMATION INDUCES LYMPHOCYTES-B TO PRODUCE HUMAN INTERLEUKIN-10 [J].
BURDIN, N ;
PERONNE, C ;
BANCHEREAU, J ;
ROUSSET, F .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 177 (02) :295-304
[9]  
CASSIDY JT, 1979, CLIN EXP IMMUNOL, V35, P296
[10]  
CHEVET D, 1993, TRANSPLANT P, V25, P1355